Allergen immunotherapy: A practice parameter third update

Task force reportAllergen immunotherapy : A practice parameter third updateChief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MDWorkgroup Contributors: Christopher Calabria, MD, Thomas Chacko, MD, Ira Finegold, MD, Michael Nelson, MD, PhD,and Richard Weber, MDTask Force Reviewers: David I. Bernstein, MD, Joann Blessing-Moore, MD, David A. Khan, MD, David M. Lang, MD,Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher Randolph, MD, Diane E. Schuller, MD,Sheldon L. Spector, MD, Stephen Tilles, MD, and Dana Wallace, MDKeywords:Allergy immunotherapy , subcutaneous immunotherapy , sublingual immunotherapy , allergic rhinitis, asthma, Hymenoptera,atopic dermatitis, anaphylaxis, epinephrine,b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy , in-tralymphatic immunotherapy , nasal immunotherapyThese parameters were developed by the Joint Task Force onPractice Parameters, representing the America

sublingual immunotherapy, allergic rhinitis, asthma, Hymenoptera, atopic dermatitis, anaphylaxis, epinephrine, b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy, in-tralymphatic immunotherapy, nasal immunotherapy These parameters were developed by the Joint Task Force on

Loading..

Tags:

  Immunotherapy, Sublingual, Sublingual immunotherapy

Information

Related search queries